Gastroesophageal reflux disease and chest pain;Malattia da reflusso gastro-esofageo e dolore toracico

Minerva Cardioangiologica

Volumn 49, Issue 3, 2001, Pages 197-209

  Pellicano, R ^a   Oliaro, E ^b   Berrutti, M ^b   Ponzetto, A ^b   Rizzetto, M ^b  

^a Ambulatori di Gastroenterologia   (Italy)

^b NONE

Author keywords

Chest pain, diagnosis; Esopagitis, diagnosis; Gastroesophageal reflux, diagnosis

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP;

BARRETT ESOPHAGUS; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMAN; PATHOPHYSIOLOGY; REVIEW; THORAX PAIN; TIME;

BARRETT ESOPHAGUS; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; PROTON PUMPS; TIME FACTORS;

EID: 0035379559     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Conférence de Consensus. Reflux gastro-oesophagien de l'adulte: «diagnostic et traitement». Gastroenterol Clin Biol 1999;23:56-65.
2. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;155:2165-73.
3. Kang JK, Ho KY. Different prevalences of reflux oesophagitis and hiatus hernia among dyspeptic patients in England and Singapore. Eur J Gastroenterol Hepatol 1999;11:845-50.
4. Frank L, Kleinman L, Ganoczy D, McQuaid K, Sloan S, Eggleston A et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to health-care utilization and quality of life. Dig Dis Sci 2000; 45:809-18.
5. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104:252-8.
6. Pellicano R, Palmas F. Patologia da reflusso gastroesofageo. Ed Minerva Medica, Torino 1999.
7. Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease. A position statement of the Italian Association of Hospital Gastroenterologist (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED) and Italian Society of Gastroenterology (SIGE). It J Gastroenterol Hepatol 1998;30:107-12.
8. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distension in reflux patients with hiatal hernia Gastroenterology 2000;118:688-95.
9. Kahrilas PJ. Gastroesophageal Reflux Disease and Its Complications. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. W.B. Saunders Company 1998:498-517.
10. Cameron AJ. Epidemiologic studies and the development of Barrett's esophagus. Endoscopy 1993;25:635-6.
11. Reynolds JC, Waronker M, Pacquing MS, Yassin RR. Barrett's esophagus. Reducing the risk of progression to adenocarcinoma. Gastroenterol Clin North Am 1999;28:917-45.
12. Ferraris R, Bonelli L, Conio M, Fracchia M, Lapertosa G, Aste H. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopie surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur J Gastroenterol Hepatol 1997;9:881-5.
13. Koop H. Reflux disease and Barrett's esophagus. Endoscopy 2000;32:101-7.
14. Coenrad M, Moslee AA, Stratchof JW, Ganesh S, Griffioen G, Lamers CB. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis? Am J Gastroenterol 1998; 93:1068-72.
15. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS et al. Effect of segment lenght on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000;132:612-20.
16. De Meester SR, De Meester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303-21.
17. Stein HJ, Stipa F, Liebermann D. What is the respective correlation between light absorption on Bilitec monitoring and bilirubin/bile acid concentration? In: Galmiche JP, Jamieson GG, Scarpignato C, editors. The esophagogastric junction. Paris: O.E.S.O. J Libbey Eurotext, 1998:472-6.
18. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Synptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
19. Velanovich V, Karmy Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. Am Surg 1998;7:649-53.
20. Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB. the omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000;14:389-96.
21. Meining A, Classen M. The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2000:95: 2692-7.
22. Fisher RS. Treatment of gastroesophageal reflux disease. In: Wolfe MM, editor. Therapy of digestive disorders. WB Saunders Company. Philadelphia 2000:3-16.
23. Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997;103:520-8.
24. Tytgat GN. Medical therapy of gastroesophageal reflux disease in secondary and tertiary care setting. Yale J Biol Med 1999;72:219-26.
25. Heading RC, Baldi F, Holloway RH, Janssens J, Jian R, McCallum RW et al. Prokinetics in the treatment of gastro-oesophageal reflux disease. Europ J Gastroenterol Hepatol 1998;10:87-93.
26. Kuijpers EJ, Meuwissen SG. The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease. Gastroenterology 2000;118:795-8.
27. Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa. Gastroenterology 2000;118: 661-9.
28. Hinder RA. Surgical therapy for GERD: selection of procedures, short and long-term results. J Clin Gastroenterol 2000; 30:S48-S50.
29. Hogan WJ, Shake R. Life after antireflux surgery. Am J Med 2000;108:181-91.
30. Field SK, Gelfand GAJ, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999; 116:766-74.
31. Sontag SJ. Why do the published data fail to clarify the relationship between gastroesophageal reflux and asthma? Am J Med 2000; 108:159-69.
32. Bowrey DJ, Peters JH, DeMeester TR. Gastroesophageal reflux disease in asthma: effects of medical and surgical antireflux therapy on asthma control. Ann Surg 2000;231:161-72.
33. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999;94:3131-8.
34. Irwin RS, Madison JM. Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med 2000;108:126-30
35. Smullen JL, Lejeune FE. Otolaryngologic manifestations of gastroesophageal reflux disease. J La State Med Soc 1999;151:115-9.
36. Johanson JF. Epidemiology of esophageal and supraesophageal reflux injuries. Am J Med 2000;108;99-103.
37. El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997;113: 755-60.
38. Gaynor EB. Laryngeal complications of GERD. J Clin Gastroenterol 2000;30:31-4.
39. Palombini BC, Castilhos Villanova CA, Araujo E, Gastal OL, Carneiro Alt D, Stolz DP et al. A pathogenic triad in chronic cough. Asthma, postnasal drip syndrome and gastroesophageal reflux disease. Chest 1999; 116:279-84.
40. Richter JE. Chest pain and gastroesophageal reflux disease. J Clin Gastroenterol 2000;30:39-41.
41. Katz PO, Castell DO. Approach to the patient with unexplained chest pain. Am J Gastroenterol 2000;95:S4-S8.
42. Bennett JR, Atkinson M. The differentiation between esophageal and cardiac pain. Lancet 1966;ii:1123-7.
43. Areskog M, Tibbling L, Wranne B. Non-infarction coronary care unit patients. Acta Med Scand 1981;209:51-7.
44. Davies AH, Lewis M, Rhodes J. "Esophageal angina" as a cause of chest pain. JAMA 1982;248:2274-8.
45. Voskuil JH, Cramer MJ, Breumelhof R, Timmer R, Smout AJ. Prevalence of esophageal disorders in patients with chest pain newly referred to the cardiologist. Chest 1996; 109:1210-4.
46. Swift GL, Davies AH, McKirdy H, Lowndes R, Lewis D, Rhodes J. A long term clinical review of patients with esophageal pain. QJM 1991;295:937-44.
47. Davies AH, Rhodes J. Follow-up of patients with esophageal angina. JAMA 1986; 255:2021.
48. Pace F, Bianchi Porro G. Malattia da reflusso gastro-esofageo e dolore toracico. In: Morelli A, Fiorucci S, editors. Malattia da reflusso gastro-esofageo. Napoli: Edises, 1996:201-9.
49. Singh S, Richter J, Hewson E et al. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med 1992;117: 824-30.
50. Chauan A, Petch MC, Schofield PM. Effect of oesophageal acid instillation on coronary flow blood. Lancet 1993;341:1309-10.
51. Schofield PM, Bennett DH, Whorwell PJ, Brooks NH, Bray CL, Ward C et al. Exertional gastroesophageal reflux: A mechanism for symptoms in patients with angina pectoris and normal coronary angiograms. Br Med J 1987;294:1459-61.
52. Johnston BT, Collins JSA, McFarland RJ, Love AHG. Are esophageal symptoms reflux-related? A study of different scoring systems in a cohort of patients with heartburn. Am J Gastroenterol 1994;89:497-502.
53. Katz PO, Dalton CB, Richter JE, Wu WC, Castell DO. Esophageal testing in patients with non-cardiac chest pain and/or dysphagia. Ann Intern Med 1987;106:593-7.
54. Clouse RE, Staiano A, Landau DW, Schlachter JL. Manometric findings during spontaneous chest pain in patients with presumed esophageal "spasm". Gastroenterology 1983;85:395-402.
55. Hewson EG, Sinclair JW, Dalton CB, Richter JE. Twenty-four hour esophageal pH monitoring: the most useful test for evaluation non-cardiac chest pain. Am J Med 1991;90: 576-83.
56. Sifrim D, Janssens J. Chest pain of esophageal origin. Curr Opin Gastroenterol 1995;11:346-50.
57. Achem SR, Kolts BE, McMath T, Richter J, Mohr D, Burton L et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997;42:2138-45.
58. Fass R, Fennerty MB, Ofman JJ, Gralneck IM, Johnson C, Camargo E et al. The clinical and economic value of a short course of omeprazole in patients with non-cardiac chest pain. Gastroenterology 1998;115:42-9.